Terns Pharmaceuticals Inc (NASDAQ: TERN) kicked off on Monday, up 69.85% from the previous trading day, before settling in for the closing price of $8.26. Over the past 52 weeks, TERN has traded in a range of $1.87-$9.03.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 16.38%. While this was happening, its average annual earnings per share was recorded -0.50%. With a float of $69.63 million, this company’s outstanding shares have now reached $87.47 million.
Terns Pharmaceuticals Inc (TERN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 20.43%, while institutional ownership is 83.20%. The most recent insider transaction that took place on Oct 01 ’25, was worth 7,407. In this transaction Chief Medical Officer of this company sold 944 shares at a rate of $7.85, taking the stock ownership to the 51,520 shares. Before that another transaction happened on Jul 01 ’25, when Company’s Chief Medical Officer sold 853 for $4.27, making the entire transaction worth $3,640. This insider now owns 52,464 shares in total.
Terns Pharmaceuticals Inc (TERN) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.28 earnings per share (EPS), higher than consensus estimate (set at -0.32) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.04% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Take a look at Terns Pharmaceuticals Inc’s (TERN) current performance indicators. Last quarter, stock had a quick ratio of 24.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.05, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.26 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
The latest stats from [Terns Pharmaceuticals Inc, TERN] show that its last 5-days average volume of 8.45 million was superior to 1.37 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 68.62%.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 82.39%, which indicates a significant increase from 75.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.90 in the past 14 days, which was higher than the 0.46 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.89, while its 200-day Moving Average is $4.99. Now, the first resistance to watch is $15.94. This is followed by the second major resistance level at $17.86. The third major resistance level sits at $19.44. If the price goes on to break the first support level at $12.44, it is likely to go to the next support level at $10.86. The third support level lies at $8.94 if the price breaches the second support level.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
The company with the Market Capitalisation of 1.23 billion has total of 87,511K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -88,850 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -24,090 K.
